Diagnosis and management of the metabolic syndrome.  An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.
Grundy
Scott M
SM
Cleeman
James I
JI
Daniels
Stephen R
SR
Donato
Karen A
KA
Eckel
Robert H
RH
Franklin
Barry A
BA
Gordon
David J
DJ
Krauss
Ronald M
RM
Savage
Peter J
PJ
Smith
Sidney C
SC
Spertus
John A
JA
Costa
Fernando
F
D000572:American Heart Association; D050197:Atherosclerosis / Q000150:complications / Q000628:therapy; D001777:Blood Coagulation / Q000187:drug effects; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy; D003937:Diagnosis, Differential; D050171:Dyslipidemias / Q000150:complications / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000628:therapy; D008019:Life Style; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D009316:National Institutes of Health (U.S.); D009765:Obesity / Q000150:complications / Q000628:therapy; D012307:Risk Factors; D014481:United States
D001786:Blood Glucose